期刊
PROTEOMICS CLINICAL APPLICATIONS
卷 8, 期 7-8, 页码 610-619出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/prca.201400038
关键词
Deuterium oxide; Heavy water; Plasma proteome; Protein dynamics; Protein turnover
资金
- NIH [HL-R37-63901, HHSN268201000035C]
- Laubisch endowment
- AHA [13POST14700031, 12PRE11610024]
Purpose: High-throughput quantification of human protein turnover via in vivo administration of deuterium oxide ((H2O)-H-2) is a powerful new approach to examine potential disease mechanisms. Its immediate clinical translation is contingent upon characterizations of the safety and hemodynamic effects of in vivo administration of (H2O)-H-2 to human subjects. Experimental design: We recruited ten healthy human subjects with a broad demographic variety to evaluate the safety, feasibility, efficacy, and reproducibility of (H2O)-H-2 intake for studying protein dynamics. We designed a protocol where each subject orally consumed weight-adjusted doses of 70% (H2O)-H-2 daily for 14 days to enrich body water and proteins with deuterium. Plasma proteome dynamics was measured using a high-resolution MS method we recently developed. Results: This protocol was successfully applied in ten human subjects to characterize the endogenous turnover rates of 542 human plasma proteins, the largest such human dataset to-date. Throughout the study, we did not detect physiological effects or signs of discomfort from (H2O)-H-2 consumption. Conclusions and clinical relevance: Our investigation supports the utility of a (H2O)-H-2 intake protocol that is safe, accessible, and effective for clinical investigations of large-scale human protein turnover dynamics. This workflow shows promising clinical translational value for examining plasma protein dynamics in human diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据